
这个市场不值得进入。当前证据不是“低门槛新市场”,而是一个靠高客单价、强功能差异和高前置投入才能跑通的高门槛市场;虽然还没出现 30+ 新品牌涌入的典型过热信号,但样本过窄,真正能复制的成功路径几乎只有 Morfone 这一条。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这个市场目前不值得进入:样本里只有 1 个可识别品牌,且唯一新品牌 Morfone 只能靠高客单价差异化产品 B0FBGMRVJL 打开局面,说明门槛高、打法偏重功能创新,不是普通小卖家容易复制的市场。 用户预算 500000 CNY 表面上够覆盖单个 ASIN 的前期铺货、物流和推广,但这类产品后续还会吃掉研发、品牌和认证成本,所以对长期入场来说并不宽裕。
Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternative solutions may pose a risk to your investment in certain markets.
这个市场目前不适合进入。 数据只看到 1 个品牌、1 个新品案例,没有出现你要求的 30~100+ 新品牌涌入,也没有价格战式的低利润海;但这并不代表机会充足,反而说明样本太窄,当前唯一能验证的成功案例是 Morfone 的单品打法,不能支撑“大量可复制机会”的判断,贸然入场风险很高。
证据上,Morfone 的 ASIN B0FBGMRVJL 是一个高毛利、低评论的成功样本:售价 $112.71,利润率 42.5%,最近月销 50 单,最近月营收约 $5,635.50,累计早期投入约 $23,361.27,其中广告约 $5,959.46;只有 17 条评论,评分 4.5。 这说明它不是靠评论堆出来的假繁荣,而是靠“高客单价 + 明确功能差异”跑通了白帽新品;可复制的点是热敷+冷敷+智能睡眠面罩的一体化定位、偏高端价位、以及 Active Sales 说明真实动销。但这类打法对产品设计、供应链和前期投放要求高,用户预算 500,000 CNY 只能覆盖单 ASIN 的前几个月启动成本,若要做到同级别体验和投放,后续还会有品牌和研发隐性成本。
结论非常直接:大品牌可以做,但必须重投入、做差异化;小品牌也“有可能”,但这次数据里没有真正的“小品牌成功案例”可抄,只有 Morfone 这一类新品牌高投入成功样本,不能当作低成本入场模板。 目前没有证据显示这个市场已经进入 30~100+ 新品牌的 oversaturation,也没有看到大量 <10% 利润的价格战品类,但单个成功案例不足以证明可持续机会;如果你要进,应该只复制 Morfone 这种高端功能整合和白帽推广逻辑,不要做低价同质化、不要用刷评思路,也不要把旧品牌当小品牌标杆。
这个市场不适合现在进入,结论很明确:表面上只有一个新品牌样本跑通了,但这不是可复制的低门槛机会,而是高客单价、高投入、强品牌化的打法。 目前看到的核心样本 Morfone 只有 1 个新上架产品就做到 42.5% 利润率、每月卖 50 件、月销 5635.5 美元,但前期投入已经到 23361.27 美元,广告就占了 5959.46 美元;这说明赚钱不是靠低成本起量,而是靠明显的资金和运营堆出来的结果。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FBGMRVJL | Morfone | 2025-10-09 | Yes | $112.71 | 50pcs | $5635.5 | 42.48% | $2393.97 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FBGMRVJL | Morfone | 2025-10-09 | Yes | $112.71 | 50pcs | $5635.5 | 42.48% | $2393.97 |
这不是一个适合大多数卖家进入的市场;当前证据显示它更像是靠差异化功能和较高投入才能跑出来的高门槛市场。 目前看不到大规模新品牌涌入导致的全面拥挤,但也绝不是低门槛红海:唯一明确成功的新品是 Morfone 的 B0FBGMRVJL,靠的是一体式睡眠面罩式设计、冷热敷一体、无需冷凝胶包这种明显功能差异,而不是低价硬拼。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
结论很明确:这个市场可以进入,但只适合有足够预算、能打品牌和投放的玩家;对小商家来说,门槛很高,不是轻松赚钱的市场。 目前看到的成功样本几乎全部集中在 Morfone,说明真正可复制的成功案例太少,市场并没有形成“多数新品牌都能活下来”的环境。
证据上,Morfone 的 B0FBGMRVJL 是唯一清晰的正面样本:新品牌、新上架、白帽打法、17条评价,仍做到 42.5% 利润率,早期投入约 23,361.27 美元,广告就占 5,959.46 美元,月销约 50 件、月营收约 5,635.50 美元。 但这不是低成本小卖家模型,而是需要明显前置投入的打法;而且当前报告里可识别的新品牌盈利样本只有 1 个,盈利新品牌占比 100% 只是因为样本极少,不能代表市场宽松。时间上,2022–2024 没有可识别的新品牌成功记录,2025 才出现这一例,说明最近才开始冒出成功案例,但不是全面放量。
对大品牌:可以试,但必须按高预算、强投放、强品牌进入;对小商家:不建议贸然进入,因为你现有 50 万 CNY 预算虽然能覆盖单个 ASIN 的前期成本,但像 B0FBGMRVJL 这种级别的成功已经吃掉约 2.34 万美元且还没算长期品牌/R&D/认证成本。 目前没有看到大量 30~100+ 新品牌涌入的证据,也没有看到利润率普遍低于 10% 的价格战信号;但成功样本过少,意味着“不是大面积红海”,而是“高门槛、成功稀缺”。可参考的对象只有 Morfone 和 ASIN B0FBGMRVJL;小商家若要做,只能按强差异化、高投入路线,不是靠低预算复制。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |